These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1406448)

  • 1. Transdermal fentanyl.
    Med Lett Drugs Ther; 1992 Oct; 34(881):97-8. PubMed ID: 1406448
    [No Abstract]   [Full Text] [Related]  

  • 2. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal fentanyl in cancer pain.
    Mosser KH
    Am Fam Physician; 1992 May; 45(5):2289-94. PubMed ID: 1575123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal fentanyl (Duragesic): respiratory arrest in adolescents.
    Raymond B; Morawiecka I
    CMAJ; 2004 Oct; 171(8):991-2. PubMed ID: 15497207
    [No Abstract]   [Full Text] [Related]  

  • 5. Mini-dose titration of the transdermal fentanyl patch--a novel approach by adjusting the area of absorption.
    Peng YR; Sun WZ; Mok MS
    J Pain Symptom Manage; 2005 Jul; 30(1):7-8. PubMed ID: 16043001
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absence of 'cross-tolerance' when switching from oral morphine to transdermal fentanyl.
    Johnson S; Faull C
    Palliat Med; 1997 Nov; 11(6):494-5. PubMed ID: 9519176
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches].
    Christrup LL; Jensen NH; Jonsson T; Sjøgren P; Steffansen B
    Ugeskr Laeger; 2009 Oct; 171(44):3215; author reply 3215. PubMed ID: 19866512
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rejoiner to debate].
    Christrup LL; Jensen NH; Jonsson T; Sjøgren P
    Ugeskr Laeger; 2009 Nov; 171(49):3637; author reply 3637. PubMed ID: 19967831
    [No Abstract]   [Full Text] [Related]  

  • 11. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs.
    Krotscheck U; Boothe DM; Boothe HW
    Vet Ther; 2004; 5(3):202-11. PubMed ID: 15578452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma concentrations of fentanyl administered by the transdermal route].
    Chauvin M; Strumza P; Guirimand F; Levron JC; Falson F; Duvaldestin P
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R154. PubMed ID: 2604113
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transcutaneous fentanyl].
    Estève M
    Cah Anesthesiol; 1994; 42(2):195-217. PubMed ID: 8087637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal fentanyl for chronic pain.
    Pasero CL; McCaffery M
    Am J Nurs; 1997 Nov; 97(11):17-8. PubMed ID: 9372703
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse rash associated with transdermal fentanyl.
    Stoukides CA; Stegman M
    Clin Pharm; 1992 Mar; 11(3):222. PubMed ID: 1535304
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects.
    Marier JF; Lor M; Potvin D; Dimarco M; Morelli G; Saedder EA
    J Clin Pharmacol; 2006 Jun; 46(6):642-53. PubMed ID: 16707411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl transdermal analgesia during pregnancy and lactation.
    Cohen RS
    J Hum Lact; 2009 Aug; 25(3):359-61. PubMed ID: 19286842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.